Articles tagged with 'Published Research' & 'Regenerative Medicine' | Cedars-Sinai Medical Center

Investigators from the Board of Governors Regenerative Medicine Institute at Cedars-Sinai are advancing stem cell technology to treat degenerative diseases of the eye. In one recent study, they determined the optimal dose and surgical method for tran...

Cedars-Sinai investigators have joined with colleagues from seven regenerative medicine institutes in the Los Angeles region to form a new working group that will share resources and maximize the impact of state funding.“The goal of this group is to ...

In 1998, scientists reported being able to derive cells from human embryos that could develop into almost any cell in the body. In 2007, the field took a huge leap when scientists discovered they could reprogram human adult skin cells to act like the...

Investigators from the Cedars-Sinai Board of Governors Regenerative Medicine Institute and Cedars-Sinai Cancer have collaborated to co-develop and test a new version of the chemotherapy workhorse doxorubicin. Their study, published in the peer-review...

Investigators from Cedars-Sinai have provided new understanding of how diabetes delays wound healing in the eye, identifying for the first time two related disease-associated changes to the cornea.The findings, published in the peer-reviewed journal ...

Cedars-Sinai investigators are working to develop a more effective treatment for one of the most common and hard-to-heal musculoskeletal injuries: torn tendons. Investigators led by Dmitriy Sheyn, PhD, assistant professor in the Cedars-Sinai Board of...

Cedars-Sinai investigators are developing a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using engineered stem cells that may eventually lead to personalized treatments. The new approach uses cells derived from huma...

Cedars-Sinai investigators, in collaboration with Axiom Space of Houston, are sending stem cells to space to explore whether microgravity can make it easier and more efficient to produce large batches of stem cells.  This is the first of a series of ...

Cedars-Sinai’s Efforts to Combat Lower Back Pain Get $2 Million Boost From CIRMInvestigators at Cedars-Sinai have received a $2 million grant from the California Institute for Regenerative Medicine (CIRM) to develop a new cell therapy that helps impr...

A new Cedars-Sinai study in collaboration with the University of California, Irvine (UCI) and the Answer ALS consortium has examined the expression of thousands of genes in stem cell generated motor neurons that are known to die in patients with amyo...

When it comes to moving stem cell advancements from the lab to the clinic, collaboration is key. And on Dec. 8-11, scientists from around the world gathered at Cedars-Sinai for the third Cell Symposium to discuss the latest developments in therapeuti...

Clive Svendsen, PhD, a pioneer in regenerative medicine, has been awarded the Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing, from the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, for his impa...

Cedars-Sinai has been awarded a five-year, $8 million grant from California’s stem cell agency to launch an innovative new clinic that will expand patients’ access to stem cell and gene therapies, increase research and training in regenerative medici...

A new method developed by scientists at Cedars-Sinai makes it easier to visualize the cell populations in organ chips, the technology that recapitulates true-to-life biology outside the body.Induced pluripotent stem cell and organ-chip technologies a...

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neur...

Investigators at Cedars-Sinai and the University of California, San Francisco (UCSF) have identified a component in the intestine that plays a critical role in repairing damaged tissue.Scientists found that endothelial cells in the lymphatic vessels ...

Two recent discoveries co-led by scientists at Cedars-Sinai may help lead to new ways to treat patients with Allan-Herndon-Dudley syndrome (AHDS), a brain development disorder that causes severe intellectual disability and problems with movement.   I...

There's a huge urgency worldwide to find new therapies that help patients with amyotrophic lateral sclerosis (ALS), a fatal neurological disorder that causes people to eventually lose the ability to walk, talk, eat and breathe.ALS attacks nerve cells...

Already pioneers in regenerative medicine, scientists at Cedars-Sinai are launching their expertise into space to see if they can elevate the next generation of stem cell and gene therapies by harnessing the near-zero gravity conditions of spacefligh...

Cancer treatments save lives. They also might cause heart damage in the process.Cedars-Sinai research scientist Arun Sharma, PhD, wants to be able to predict when this might happen. As the head of a new laboratory in the Cedars-Sinai Board of Governo...

A new cloud-based data resource co-developed by scientists at Cedars-Sinai provides the research community with a comprehensive set of tools to help identify new subtypes of amyotrophic lateral sclerosis (ALS), a fatal neurological disorder.The web-b...

The secret to producing large batches of stem cells more efficiently may lie in the near-zero gravity conditions of space. Scientists at Cedars-Sinai have found that microgravity has the potential to contribute to life-saving advances on Earth by fac...

Stem cell scientists have revealed the origins of a common ovarian cancer by modeling fallopian tube tissues, allowing them to characterize how a genetic mutation puts women at high risk for this cancer. The created tissues, known as organoids, hold ...

Scientists from Cedars-Sinai are gearing up to send stem cells into space to test whether it is possible to produce large batches in zero gravity for use in treating a variety of diseases back on Earth.The investigators are partnering with a private ...

Cedars-Sinai has been awarded $11.99 million by California's stem cell agency to launch a clinical trial testing a potential gene and stem cell therapy for amyotrophic lateral sclerosis (ALS).ALS, or Lou Gehrig's disease, is a progressive neurodegene...

A team of researchers from UCLA, Cedars-Sinai and the Cystic Fibrosis Foundation has developed a first-of-its-kind molecular catalog of cells in healthy lungs and the lungs of people with cystic fibrosis.The catalog, described today in the journal Na...

Cedars-Sinai has launched a center to manufacture the next generation of stem cell and gene therapies that will enable biomedical researchers, government medical programs, commercial entities and others to develop new biologic drugs and propel novel ...

A new study shows that SARS-CoV-2, the virus that causes COVID-19 (coronavirus), can infect heart cells in a lab dish, indicating it may be possible for heart cells in COVID-19 patients to be directly infected by the virus. The discovery, published t...

Is the future of personalized medicine out of this world? Cedars-Sinai is trying to find out by launching special stem cells into space to see if they multiply better there.The Cedars-Sinai Board of Governors Regenerative Medicine Institute is partne...

Orthopaedic surgeons increasingly rely on new therapies to treat a range of muscular-skeletal conditions. But surgeons do not always agree on the use or effectiveness of the treatments that include stem cells and platelet-rich plasma.Now a center, co...